Literature DB >> 30737847

Cerebral blood volume mapping using Fourier-transform-based velocity-selective saturation pulse trains.

Qin Qin1,2, Yaoming Qu3, Wenbo Li1,2, Dapeng Liu1,2, Taehoon Shin4,5, Yansong Zhao6, Doris D Lin1, Peter C M van Zijl1,2, Zhibo Wen3.   

Abstract

PURPOSE: Velocity-selective saturation (VSS) pulse trains provide a viable alternative to the spatially selective methods for measuring cerebral blood volume (CBV) by reducing the sensitivity to arterial transit time. This study is to compare the Fourier-transform-based velocity-selective saturation (FT-VSS) pulse trains with the conventional flow-dephasing VSS techniques for CBV quantification.
METHODS: The proposed FT-VSS label and control modules were compared with VSS pulse trains utilizing double refocused hyperbolic tangent (DRHT) and 8-segment B1-insensitive rotation (BIR-8). This was done using both numerical simulations and phantom studies to evaluate their sensitivities to gradient imperfections such as eddy currents. DRHT, BIR-8, and FT-VSS prepared CBV mapping was further compared for velocity-encoding gradients along 3 orthogonal directions in healthy subjects at 3T.
RESULTS: The phantom studies exhibited more consistent immunity to gradient imperfections for the utilized FT-VSS pulse trains. Compared to DRHT and BIR-8, FT-VSS delivered more robust CBV results across the 3 VS encoding directions with significantly reduced artifacts along the superior-inferior direction and improved temporal signal-to-noise ratio (SNR) values. Average CBV values obtained from FT-VSS based sequences were 5.3 mL/100 g for gray matter and 2.3 mL/100 g for white matter, comparable to literature expectations.
CONCLUSION: Absolute CBV quantification utilizing advanced FT-VSS pulse trains had several advantages over the existing approaches using flow-dephasing VSS modules. A greater immunity to gradient imperfections and the concurrent tissue background suppression of FT-VSS pulse trains enabled more robust CBV measurements and higher SNR than the conventional VSS pulse trains.
© 2019 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  Fourier-transform-based velocity-selective saturation; arterial spin labeling; cerebral blood volume; eddy current; velocity-selective pulse train

Mesh:

Substances:

Year:  2019        PMID: 30737847      PMCID: PMC6820852          DOI: 10.1002/mrm.27668

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  42 in total

1.  Fast measurement of blood T1 in the human carotid artery at 3T: Accuracy, precision, and reproducibility.

Authors:  Wenbo Li; Peiying Liu; Hanzhang Lu; John J Strouse; Peter C M van Zijl; Qin Qin
Journal:  Magn Reson Med       Date:  2016-07-20       Impact factor: 4.668

2.  An optimized velocity selective arterial spin labeling module with reduced eddy current sensitivity for improved perfusion quantification.

Authors:  James A Meakin; Peter Jezzard
Journal:  Magn Reson Med       Date:  2012-05-03       Impact factor: 4.668

3.  A fully automated method for quantitative cerebral hemodynamic analysis using DSC-MRI.

Authors:  Atle Bjørnerud; Kyrre E Emblem
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

4.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results.

Authors:  L Ostergaard; A G Sorensen; K K Kwong; R M Weisskoff; C Gyldensted; B R Rosen
Journal:  Magn Reson Med       Date:  1996-11       Impact factor: 4.668

5.  What is the correct value for the brain--blood partition coefficient for water?

Authors:  P Herscovitch; M E Raichle
Journal:  J Cereb Blood Flow Metab       Date:  1985-03       Impact factor: 6.200

6.  Velocity-selective magnetization-prepared non-contrast-enhanced cerebral MR angiography at 3 Tesla: Improved immunity to B0/B1 inhomogeneity.

Authors:  Qin Qin; Taehoon Shin; Michael Schär; Hua Guo; Hanwei Chen; Ye Qiao
Journal:  Magn Reson Med       Date:  2015-05-02       Impact factor: 4.668

7.  Measurement of absolute arterial cerebral blood volume in human brain without using a contrast agent.

Authors:  Jun Hua; Qin Qin; James J Pekar; Peter C M van Zijl
Journal:  NMR Biomed       Date:  2011-05-24       Impact factor: 4.044

8.  On the measurement of absolute cerebral blood volume (CBV) using vascular-space-occupancy (VASO) MRI.

Authors:  Jinsoo Uh; Kelly Lewis-Amezcua; Rani Varghese; Hanzhang Lu
Journal:  Magn Reson Med       Date:  2009-03       Impact factor: 4.668

9.  Identification and reduction of image artifacts in non-contrast-enhanced velocity-selective peripheral angiography at 3T.

Authors:  Taehoon Shin; Qin Qin; Jang-Yeon Park; Robert S Crawford; Sanjay Rajagopalan
Journal:  Magn Reson Med       Date:  2015-08-26       Impact factor: 4.668

10.  Velocity-selective-inversion prepared arterial spin labeling.

Authors:  Qin Qin; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2015-10-28       Impact factor: 4.668

View more
  12 in total

1.  Improved velocity-selective-inversion arterial spin labeling for cerebral blood flow mapping with 3D acquisition.

Authors:  Dapeng Liu; Feng Xu; Wenbo Li; Peter C van Zijl; Doris D Lin; Qin Qin
Journal:  Magn Reson Med       Date:  2020-05-13       Impact factor: 4.668

2.  In vivo magnetic resonance imaging and spectroscopy. Technological advances and opportunities for applications continue to abound.

Authors:  Peter van Zijl; Linda Knutsson
Journal:  J Magn Reson       Date:  2019-07-09       Impact factor: 2.229

3.  Improved velocity-selective labeling pulses for myocardial ASL.

Authors:  Vanessa Landes; Ahsan Javed; Terrence Jao; Qin Qin; Krishna Nayak
Journal:  Magn Reson Med       Date:  2020-03-15       Impact factor: 4.668

4.  Three-dimensional whole-brain mapping of cerebral blood volume and venous cerebral blood volume using Fourier transform-based velocity-selective pulse trains.

Authors:  Wenbo Li; Dapeng Liu; Peter C M van Zijl; Qin Qin
Journal:  Magn Reson Med       Date:  2021-05-06       Impact factor: 4.668

5.  Ensuring both velocity and spatial responses robust to B 0 / B 1 + field inhomogeneities for velocity-selective arterial spin labeling through dynamic phase-cycling.

Authors:  Dapeng Liu; Wenbo Li; Feng Xu; Dan Zhu; Taehoon Shin; Qin Qin
Journal:  Magn Reson Med       Date:  2020-12-08       Impact factor: 4.668

6.  Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.

Authors:  Yaoming Qu; Dexia Kong; Haitao Wen; Xiaochan Ou; Qihong Rui; Xianlong Wang; Doris D Lin; Qin Qin; Zhibo Wen
Journal:  Eur Radiol       Date:  2022-01-23       Impact factor: 5.315

7.  Spatial dependency and the role of local susceptibility for velocity selective arterial spin labeling (VS-ASL) relative tagging efficiency using accelerated 3D radial sampling with a BIR-8 preparation.

Authors:  James H Holmes; Mu-Lan Jen; Laura B Eisenmenger; Tilman Schubert; Patrick A Turski; Kevin M Johnson
Journal:  Magn Reson Med       Date:  2021-02-21       Impact factor: 3.737

8.  Ultrafast B1 mapping with RF-prepared 3D FLASH acquisition: Correcting the bias due to T1 -induced k-space filtering effect.

Authors:  Dan Zhu; Michael Schär; Qin Qin
Journal:  Magn Reson Med       Date:  2022-04-05       Impact factor: 3.737

9.  Magnetic resonance angiography and perfusion mapping by arterial spin labeling using Fourier transform-based velocity-selective pulse trains: Examination on a commercial perfusion phantom.

Authors:  Feng Xu; Dan Zhu; Hongli Fan; Hanzhang Lu; Dapeng Liu; Wenbo Li; Qin Qin
Journal:  Magn Reson Med       Date:  2021-05-02       Impact factor: 4.668

10.  T2-Weighted Whole-Brain Intracranial Vessel Wall Imaging at 3 Tesla With Cerebrospinal Fluid Suppression.

Authors:  Lei Zhang; Yanjie Zhu; Yulong Qi; Liwen Wan; Lijie Ren; Yi Zhu; Na Zhang; Dong Liang; Ye Li; Hairong Zheng; Xin Liu
Journal:  Front Neurosci       Date:  2021-06-25       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.